Glen writes: "I suppose my point is that these numbers, $60k, $51k, $90k seem wrong to me in some ... ethical? ... sense. "
If we assume that more and more people will have cancer because people will live longer, and other diseases will have good treatments, then basically we're talking about billions of people around the world that may benefit from these treatments, and say 50-100 million in the US in a few decades? There will be other diseases that benefit from high-priced treatments too, but just the big C by itself could break the bank. It doesn't matter if everyone is paying into insurance (directly or indirectly) because the costs won't be sustainable. It seems the pricing is aggressive, in the hopes that some insurer will agree to it, but often it seems the drug company will agree to a smaller amount. Would be nice to see open source competitors emerge, as the technology emerges to make that affordable. Marcus ============================================================ FRIAM Applied Complexity Group listserv Meets Fridays 9a-11:30 at cafe at St. John's College to unsubscribe http://redfish.com/mailman/listinfo/friam_redfish.com FRIAM-COMIC http://friam-comic.blogspot.com/ by Dr. Strangelove
